bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2022.05.21.492921

Development of fluoroquinolone resistance through antibiotic tolerance in Campylobacter jejuni

Park, M.·Kim, J.·Feinstein, J.·Lang, K. S.·Ryu, S.·Jeon, B.
View original source ↗Export metadata ↓

Abstract

Antibiotic tolerance not only enables bacteria to survive under acute antibiotic exposures but also provides bacteria with a window of time to develop antibiotic resistance. Campylobacter jejuni is increasingly resistant to clinically important antibiotics, particularly fluoroquinolones (FQs). Currently, little is known about antibiotic tolerance and its effects on resistance development in C. jejuni. Here, we show that exposure to ciprofloxacin and tetracycline at concentrations 10 and 100 times higher than the minimum inhibitory concentration (MIC) induce antibiotic tolerance in C. jejuni, whereas gentamicin and erythromycin treatment cause cell death. Interestingly, FQ resistance is rapidly developed in C. jejuni after tolerance induction by ciprofloxacin and tetracycline. Furthermore, alkyl hydroperoxide reductase plays a critical role in preventing FQ resistance development in C. jejuni during antibiotic tolerance by alleviating oxidative stress. Together, these results demonstrate that exposure of C. jejuni to antibiotics used to treat campylobacteriosis can induce antibiotic tolerance and that FQ-resistant (FQR) C. jejuni rapidly emerges through tolerance induction by FQs and non-FQ antibiotics. Work presented in this study shows mechanisms underlying the high prevalence of FQR C. jejuni and provides an insight into the effects of antibiotic tolerance on resistance development. ImportanceAntibiotic tolerance compromises the efficacy of antibiotic treatment by extending bacterial survival and developing mutations associated with antibiotic resistance. Despite growing public health concerns about antibiotic resistance in C. jejuni, antibiotic tolerance has not yet been investigated in this important zoonotic pathogen. Here, our results show that exposure of C. jejuni to ciprofloxacin and tetracycline, a common agricultural antibiotic, develops antibiotic tolerance, which subsequently facilitates the emergence of FQR C. jejuni. Since antibiotic-resistant C. jejuni is transmitted primarily from animals to humans, our study suggests that non-FQ drugs, such as tetracycline, used for animals can also promote FQ resistance development by inducing antibiotic tolerance in C. jejuni. Overall, the findings in this study help us understand mechanisms of resistance development through the induction of antibiotic tolerance.

Source connections

Explore related subjects

microbiologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Park, M., Kim, J., Feinstein, J., Lang, K. S., Ryu, S., Jeon, B.. 2022-05-21. Development of fluoroquinolone resistance through antibiotic tolerance in Campylobacter jejuni. https://doi.org/10.1101/2022.05.21.492921

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗
bioRxiv2026

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗
bioRxiv2026

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗